This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joseph S. Alpert, MD

Arch Intern Med. 1983;143(8):1522-1523.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Accurate, rapid diagnosis of myocardial infarction is an important goal from a therapeutic as well as cost-effective point of view. The more rapidly the clinician can diagnose acute myocardial infarction, the sooner appropriate therapy can be initiated. However, daily charges for hospitalization in a coronary care unit in the United States frequently exceed $500. Thus, admission to the hospital for suspected myocardial infarction is often expensive, particularly if the patient remains in intensive care for two to three days while infarction is "ruled out." What laboratory test should be obtained to confirm the clinical diagnosis of myocardial infarction in these cost-conscious times? In this issue of the ARCHIVES (p 1541), Fisher et al offer one rational answer to the question aimed at decreasing the cost of hospitalization for patients with suspected myocardial infarction. Their observations support earlier recommendations for serial sampling of only the enzymes creatine kinase (CK)/CK-MB in this . . . [Full Text PDF of this Article]

Author Affiliations
Department of Medicine Division of Cardiovascular Medicine University of Massachusetts Medical Center and School Worcester, MA 01605

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?